Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive
Read More
Eli Lilly and Co
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake |
Read More
Stocks making the biggest moves premarket: Bumble, Hims & Hers Health, Blue Owl, Netskope &
Check out the companies making headlines before the bell. Bumble — Bumble shares popped about 21% after the dating app
Read More
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,
Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.
Read More
Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino’s Pizza and more
Check out the companies making headlines before the bell. Arcellx — The biotech stock surged 78% after Gilead Sciences said
Read More
Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18%
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies
Read More
FDA says Novo Nordisk’s TV ad for obesity pill includes ‘false or misleading’ claims
The Food and Drug Administration said Novo Nordisk’s TV advertisement for its newly launched Wegovy pill for obesity included “false
Read More
Stocks making the biggest moves midday: Amazon, Centene, Roblox and more
Check out the companies making headlines in midday trading. Centene — Shares of the health insurance provider slid 5%. Guidance
Read More